Quest Diagnostics/$DGX
1D1W1MYTD1Y5YMAX
About Quest Diagnostics
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
- Ticker
- $DGX
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 51,500
- Headquarters
- Secaucus, United States
- Website
- www.questdiagnostics.com
DGX Metrics
BasicAdvanced
$26B
25.01
$9.42
0.57
$3.32
1.46%
Price and volume
Market cap
$26B
Beta
0.57
52-week high
$240.13
52-week low
$171.18
Average daily volume
982K
Dividend rate
$3.32
Financial strength
Current ratio
1.591
Quick ratio
1.282
Long term debt to equity
78.402
Total debt to equity
80.808
Dividend payout ratio (TTM)
34.18%
Interest coverage (TTM)
6.27%
Profitability
EBITDA (TTM)
2,272
Gross margin (TTM)
33.19%
Net profit margin (TTM)
9.19%
Operating margin (TTM)
14.58%
Effective tax rate (TTM)
22.33%
Revenue per employee (TTM)
$220,000
Management effectiveness
Return on assets (TTM)
6.43%
Return on equity (TTM)
14.60%
Valuation
Price to earnings (TTM)
25.011
Price to revenue (TTM)
2.241
Price to book
3.45
Price to tangible book (TTM)
-7.93
Price to free cash flow (TTM)
19.205
Free cash flow yield (TTM)
5.21%
Free cash flow per share (TTM)
12.264
Dividend yield (TTM)
1.41%
Forward dividend yield
1.46%
Growth
Revenue change (TTM)
9.87%
Earnings per share change (TTM)
12.83%
3-year revenue growth (CAGR)
6.81%
10-year revenue growth (CAGR)
4.42%
3-year earnings per share growth (CAGR)
11.02%
10-year earnings per share growth (CAGR)
5.09%
3-year dividend per share growth (CAGR)
6.61%
10-year dividend per share growth (CAGR)
7.85%
What the Analysts think about DGX
Analyst ratings (Buy, Hold, Sell) for Quest Diagnostics stock.
DGX Financial Performance
Revenues and expenses
DGX Earnings Performance
Company profitability
DGX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.